>>Back
Lupin Pharmaceuticals introduces authorized generic of Celebrex Capsules
- Publisher:
- Publication:2014/12/12
Pharma Major Lupin Limited announced today that its US subsidiary, Lupin Pharmaceuticals Inc. (collectively Lupin) has launched the authorized generic for G.D. Searle LLC's (a subsidiary of Pfizer Inc.) Celebrex® Capsules (Celebrex) 50 mg, 100 mg, 200 mg and 400 mg strengths. Lupin had earlier signed a licensing agreement with Pfizer Inc. regarding Celebrex.
Celebrex® Capsules had annual U.S sales of US$ 2.54 billion (IMS MAT September, 2014).
Source:
Lupin Ltd